Precision Digital Health (PDH) is proud to announce that we will be participating as a Bronze level sponsor in the 2023 Decentralized Clinical Trials Conference from April 18-20, 2023, in Boston, MA. Thomas Wells, CEO and Co-Founder of PDH will be the Chairperson for Day 1’s General Session.
The event being held in collaboration with Tufts Center for the Study of Drug Development, will host over 40 industry speakers and is expected to draw around 175 attendees globally from pharmaceutical and biotechnology companies as well as academic and government institutions. Some of the companies sending delegates to the conference are Pfizer, Eli Lilly, Novo Nordisk, Astra Zeneca, Boeringer Ingelheim, CSL Behring, Novartis and Glaxo Smith Klein.
The main theme of the conference is “Unravel the hype, leverage the benefits and efficiently run your next clinical trial with confidence”.
To see the full speaker and session line up and to register for your place, visit https://informaconnect.com/decentralized-clinical-trials/
